2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow HYQVIA: new trials by email Literature Review of HYQVIA trials Research Report on HYQVIA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects HYQVIA, KIOVIG, Cuvitru - Primary Immunodeficiency Diseases (PID) | Phase 4 | Completed | Baxalta now part of Shire | 42 | 2017-05-30 | 2023-01-11 |
| IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia IgHy10 - Primary Immunodeficiency | Phase 4 | Completed | University Hospital, Lille | 22 | 2016-11-11 | 2019-06-25 |
Primary Immunodeficiency Diseases (2)
Baxalta now part of Shire (1) · University Hospital, Lille (1)
France (2) · Czechia (1) · Denmark (1) · Greece (1) · Hungary (1) · Slovakia (1) · Sweden (1) · United Kingdom (1)
2016 (2)